Business Wire

Strand Therapeutics Announces First Patient Dosed with Programmable mRNA Therapy STX-001 in Phase 1 Trial for Solid Tumors

BOSTON--(BUSINESS WIRE)--Strand Therapeutics, the world’s first programmable mRNA company developing curative therapies for cancer, autoimmune diseases, and beyond, today announced the first patient ...
Morningstar

Strand Therapeutics to Present Preclinical Data on Its Programmable mRNA In Vivo CAR-T Platform at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Strand Therapeutics to Present Preclinical Data on Its Programmable mRNA In Vivo CAR-T Platform at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Programmable circRNA platform ...
STAT

Scientists show that mRNA therapy can be delivered as a capsule

Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. An oral capsule can efficiently deliver liquid mRNA therapy directly to the gut, a possible new ...

New Study Shows How mRNA Vaccines Could Transform Cancer Treatment

A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer ...